Genentech’s Avastin wins lung cancer approval

October 12 2006

The FDA yesterday approved Genentech’s Avastin for use in treating non-small cell lung cancer.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.